author-photo

Anthony W. Crispino

2

Papers

5

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Baseline circulating tumor cell count as a prognostic marker of PSA response and disease progression in metastatic castrate sensitive prostate cancer (SWOG S1216).

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
Baseline circulating tumor cell (CTC) count as a prognostic marker of PSA response and progression in metastatic castrate sensitive prostate cancer (mCSPC): Results from SWOG S1216, a phase III randomized trial of androgen deprivation plus orteronel (cyp17 inhibitor) or bicalutamide.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)